Skip to main content
Premium Trial:

Request an Annual Quote

Genizon Begins Offering SNP-Genotyping Services on Illumina Technology

NEW YORK (GenomeWeb News) - Genizon BioSciences today said it has begun providing SNP-genotyping and statistical-analysis services.

Genizon performs genotyping with eight Illumina BeadArray instruments, custom Illumina Infinium chips, and GoldenGate marker sets.

The company also performs genetic analysis with its own platform, GeneSys. The system is capable of genotyping as many as 100 million genotypes per day.

All services will be performed at Genizon's Montreal-based GLP-compliant facilities.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.